Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Oncotelic Therapeutics (QB) (OTLC)

Oncotelic Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OTLC
DateTimeSourceHeadlineSymbolCompany
02/02/202422:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
30/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
23/08/202315:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
18/08/202322:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
13/07/202314:25Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
13/07/202314:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
30/06/202314:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
30/06/202314:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
20/06/202317:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
16/06/202317:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
31/05/202314:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
19/05/202321:45Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
02/05/202322:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
20/04/202311:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OTLCOncotelic Therapeutics Inc (QB)
14/04/202322:02Edgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/04/202311:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
02/03/202314:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
07/12/202213:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
25/11/202214:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
18/11/202222:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
14/11/202219:25Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
28/09/202214:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
29/08/202214:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
22/08/202213:32Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/08/202219:34Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/07/202212:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
22/06/202213:47Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
23/05/202211:22Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
11/05/202222:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/04/202221:28Edgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:OTLC